Ten patients with chronic obstructive pulmonary disease without complicating cor pulmonale were studied by right and left heart catheterization. Hemodvnamic and respiratory observations were made during a control period and during the infusion of 1 g of aminophylline. Aminophylline produced a significant reduction in mean pulmonary artery pressure from 19.7 mm Hg to 14.8 mm Hg, right ventricular end-diastolic pressure from 3.4 mm Hg to 1.4 mm Hg, left ventricular end-diastolic pressure from 6.5 mm Hg to 2.9 mm Hg, and the brachial artery mean pressure from 96.7 mm Hg to 86.2 mm Hg. The heart rate, oxygen consumption, and cardiac index increased. There was a significant fall in both peripheral and pulmonary vascular resistance. Evidence is presented to suggest that the decrease in pulmonary artery and systemic pressures was due to pulmonary and peripheral arteriolar dilatation.
SUMMARY
Ten patients with chronic obstructive pulmonary disease without complicating cor pulmonale were studied by right and left heart catheterization. Hemodvnamic and respiratory observations were made during a control period and during the infusion of 1 g of aminophylline. Aminophylline produced a significant reduction in mean pulmonary artery pressure from 19.7 mm Hg to 14.8 mm Hg, right ventricular end-diastolic pressure from 3.4 mm Hg to 1.4 mm Hg, left ventricular end-diastolic pressure from 6.5 mm Hg to 2.9 mm Hg, and the brachial artery mean pressure from 96.7 mm Hg to 86.2 mm Hg. The heart rate, oxygen consumption, and cardiac index increased. There was a significant fall in both peripheral and pulmonary vascular resistance. Evidence is presented to suggest that the decrease in pulmonary artery and systemic pressures was due to pulmonary and peripheral arteriolar dilatation. ADDITIONAL Ventilation-perfusion ratios IN PREVIOUS STUDIES from this laboratory the effects of an intravenous infusion of aminophylline have been studied in patients with congestive heart failure secondary to hypertensive or arteriosclerotic heart disease or both,' and in patients with cor pulmonale secondary to chronic bronchitis, or emphysema or both.2 In the presence of cor pulmonale, aminophylline was shown to reduce pulmonary and brachial artery pressures and the filling pressure of both ventricles. There was no change in cardiac output, but a significant decline in pulmonary vascular resistance occurred and evidence was presented suggesting that aminophylline induced pulmonary arteriolar dilatation.
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The present study was undertaken to assess the effects of an intravenous infusion of aminophylline in patients with chronic obstructive pulmonary disease without cor pulmonale.
Methods
Ten patients with chronic bronchitis or obstructive pulmonary emphysema, or both, without complicating cor pulmonale were studied. All patients had normal heart size on radiological examination and normal electrocardiograms. There was no clinical evidence of coronary or valvular heart disease and none had diastolic hypertension. Their physical characteristics and pulmonary function tests are shown in table 1. All patients were able to lie supine with one or two pillows for the 2-hour study period, and none was in acute respiratory distress. Studies were carried out in the fasting, postabsorptive state without premedication. Under local anesthesia the right brachial artery and two accompanying veins were isolated. A double-lumen no.-9 Cournand catheter was inserted into the right side of the heart so that its distal lumen lay in the pulmonary artery and its proximal lumen in the right ventricle. A no.-6 Cournand catheter was passed to the level of the axillary vein. A no.-8 Sones catheter was advanced from the right brachial artery into the left ventricle and a Cournand needle was inserted into the left brachial artery. The patients were allowed to rest for 15 minutes and then, during a 20to 30-minute control period, three or four determinations were made of the pressures in the right ventricle, pulmonary artery, left ventricle, and brachial artery, and one determination of the cardiac output was made by the direct Fick method. One gram of aminophylline* diluted to 30 ml with normal saline was then infused over a 30-minute period through the axillary vein catheter by a constant infusion pump.t Minute ventilation and intravascular and intracardiac pressures were measured at 5-minute intervals until the infusion was completed. The cardiac output was measured during the final 2 minutes of the infusion in all patients, and in six patients the cardiac output was also measured between the fifteenth and seventeenth minute of infusion.
Blood samples from the pulmonary artery and brachial artery were analyzed by the method of Van Slyke and Neill3 for oxygen and carbon dioxide content. Arterial pH was measured with a glass electrode.* The partial pressure of carbon dioxide was calculated from these determinations. Expired air was collected in a Tissot spirometer and analyzed for carbon dioxide and oxygen by the Micro-Scholander technique.4 All pressures were measured with Statham strain-gauges from a zero pressure level 5 cm. below the angle of Louis and were registered with a photographic recorder. § Systolic and diastolic pressures were calculated by averaging individual systolic and diastolic points over at least two respiratory cycles, and the mean pressures in the brachial and pulmonary arteries were obtained by electronic integration.
Results
Typical hemodynamic and respiratory re-*AminophyllineeGlaxo-Allenbury (Canada) Lim The hemodynamic and respiratory effects of aminophylline in a patient with chronic obstructive pulmonary disease. (Case 1086.) sponses to aminophylline are shown in figure 1, and the data for each patient appear in table 2. Only one set of control pressures taken during the determination of the preinfusion cardiac output is shown for each subject, this being similar to the other control values. The results obtained at the midpoint and during the final 2 minutes of the infusion are also shown. A summary and statistical analysis of the various parameters during the control period and during the final 2 minutes of infusion are included in this table.
During the control period, three patients had pulmonary artery mean pressures exceeding 20 mm Hg, and three patients had right ventricular end-diastolic pressures exceeding 5 mm Hg. One patient had elevation of the Circulation, Volume XXXV, February 1967 left ventricular end-diastolic pressure. The cardiac index was within normal limits (2.5 to 3.5 L/min) in six patients, low in two, and elevated in two. The partial pressure of carbon dioxide was above normal (46 mm Hg) in five patients, and the arterial oxygen saturation was below normal (92%) in eight patients.
During the infusion period the pulmonary artery systolic, diastolic, and mean pressures, the right ventricular end-diastolic pressure, brachial artery mean pressure, and the left ventricular end-diastolic pressure fell in each patient. These pressure changes were evident within 10 minutes of infusion and reached a plateau during the final 10 minutes of the infusion period. When the control values are compared to the values during the final 2 Heinodynanaric and Respiratory Responses to Aminophylline PARKER ET AL. (P = 0.002), and the change in brachial artery diastolic pressure was not statistically significant.
The average value for oxygen consumption increased from 137.8 ml/min/m2 to 170.5 ml/ min/m2 during the final 2 minutes of infusion (P < 0.001). The cardiac index increased from 3.15 L/min during the control period to 3.99 L/min during the final 2 minutes of infusion (P=0.003). The heart rate rose from 85 beats per minute during the control period to 110 beats per minute during the final 2 minutes of infusion (P <0.001). There was Circulation, Volume XXXV, February 1967 no change in stroke volume during the infusion period.
The calculated total peripheral resistance fell from 1,477 dynes sec cm-5 during the control period to 1,089 dynes sec cm-5 during the final 2 minutes of infusion (P <0.001). The pulmonary vascular resistance decreased from 222 dynes sec cm-5 to 169 dynes sec cm-5 during the final 2 minutes of infusion (P= 0.015).
The stroke work of the left ventricle decreased from 89.1 g-m/beat to 78.6 g-m/ beat (P = 0.04) and the stroke work of the CONTROL AMINOPHYLLINẼ~I NFUSION Figure 2 Pulmonary artery mean pressures for each patient during the control period and at intervals during the infutsion of aminophylline. right ventricle fell from 18.7 g-m/beat to 13.9 g-m/beat (P 0.04) between the control period and the final 2 minutes of the infusion.
During the infusion the minute ventilation increased from 5.3 L/min/m2 to 8.2 L/min/ m2 (BTPS) (P 0.003). The respiratory rate increased from 17.3 to 19.0 (P = 0.02), and there was a significant increase in the calculated alveolar ventilation from 2.76 L/min/ m2 to 4.03 L/min/m2 (BTPS) (P<0.001). This increase in alveolar ventilation was associated with a fall in the carbon dioxide tension in arterial blood from 46.6 mm Hg to 40.0 mm Hg during the final 2 minutes of infusion (P < 0.001). There was a corresponding increase in arterial blood pH from 7.36 to 7.41 (P < 0.001). In spite of the increase in alveolar ventilation the average arterial oxygen saturation did not change. The arterial oxygen saturation did, however, increase in five and decreased in two patients.
In six patients complete hemodynamic data were obtained between the fifteenth and seventeenth minutes of the infusion. The cardiac index increased from 3.47 L/min to 4.02 L/min (P = 0.04) although the increase in oxygen consumption from 140.2 ml/min/m2 to 154.8 ml/min/m2 was statistically insignificant (P = 0.2). The calculated total peripheral resistance fell from 1,240 dynes sec cm-4 to 1,067 dynes sec cm-5 (P = 0.03) but the decline in pulmonary vascular resistance from 140.7 dynes sec cm-5 to 117.2 dynes sec cm-5 was not significant (P -0.15).
Discussion
All the patients studied had clinical evidence of chronic obstructive pulmonary disease. The pulmonary function tests (table 1) showed variable degrees of impairment although all of the patients showed moderate to severe impairment of the maximum breathing capacity. Case 661, a patient who had small lung volumes had radiological evidence of bullae but had long-standing symptoms of obstructive pulmonary disease. Five patients showed hypercapnia and eight showed low arterial oxygen saturation. Three patients had pulmonary hypertension, but none had cardiac enlargement or past or present evidence of heart failure and thus according to the definition of Harvey and Ferrer5 could not be classified as having complicating cor pulmonale.
During the infusion of aminophylline there was an increase in cardiac index although in four cases there was little change. The increase in cardiac index was associated with an increase in oxygen consumption, which could have been due in part to increased work of breathing but could also have been due to restlessness during the latter part of the study. The respiratory quotients, however, were normal during the final measurement of oxygen consumption in all patients.
Infusion of aminophylline produced reductions of the filling pressures of both ventricles and the mean pressures in the pulmonary and systemic circulation in association with an elevation of the cardiac index. If there were no associated changes in pulmonary arteriolar tone, the fall in the distending pressures in the pulmonary arterial and venous circulations would allow the resistance vessels of the lungs to collapse, creating an increase in pulmonary vascular resistance. The fact that the calculated resistance actually decreased indicates pulmonary arteriolar dilatation or a reduction in pulmonary arteriolar tone. This could represent generalized pulmonary arteriolar dilatation or an opening of a previously closed vascular bed. These findings are similar to our observations in patients with cor pulmonale,2 and to the studies of Zimmerman6 in patients with asthma and chronic cor pulmonale. The animal studies carried out by Borst and associates7 and Barer and Gunning8 also showed evidence that aminophylline produced pulmonary arteriolar dilatation.
The mechanism whereby aminophylline produces pulmonary arteriolar dilatation or a reduction in pulmonary arteriolar tone is not clear. Aminophylline by reducing airway ob-struction9 could reduce endobronchial pressure and secondarily reduce pulmonary vascular resistance. No data are available in study, but in the absence of gross bronchospasm, the changes in endobronchial pressure would probably be too small to account for the observed changes in resistance. It has been shown that a reduction in hydrogen ion concentration is associated with pulmonary arteriolar dilatation in patients with chronic pulmonary disease.10 In this study there was however no good correlation between the changes in arterial pH or PaCO2 and the reduction in pulmonary artery pressure. Aminophylline could lower pulmonary artery pressure by reducing pulmonary blood volume but we have not studied this parameter.
The other mechanism whereby aminophylline could reduce pulmonary artery pressure would be by increasing alveolar oxygen tension. It was shown in this study that aminophylline increased alveolar ventilation but this had a variable effect on the arterial oxygen saturation. In two patients there was a significant fall in arterial oxygen saturation, Circulation, Volume XXXV, February 1967 an increase occurred in five, and in three patients there was no significant change. In spite of this variable effect on arterial oxygen saturation, the pulmonary artery pressure fell in every case and thus we do not think that improvement in alveolar oxygen tension was of prime importance in lowering pulmonary vascular resistance. In view of these observations, we consider that the changes in pulmonary vascular resistance are the result of a direct effect of aminophylline on the pulmonary arteriolar bed.
As with the pulmonary vascular bed, the reduction in calculated total peripheral resistance in the presence of a decrease in the distending pressures in the peripheral vascular bed can be taken as evidence of peripheral arteriolar dilatation or a reduction in peripheral arteriolar tone. This probably represents a direct effect of aminophylline on the peripheral resistance vessels. We have no information in this study on the effect of aminophylline on the peripheral venous circulation, although it has been shown that this drug increases peripheral venous distensibility." In the previous study in patients with cor pulmonale,2 the decrease in calculated total peripheral resistance was not statistically significant. The explanation for this difference in the two groups is not clear. The patients with cor pulmonale did, however, have lower arterial oxygen saturation, higher arterial carbon dioxide tensions and cardiac outputs, and perhaps had peripheral arteriolar dilatation during the control period.
Aminophylline in animal studies has been shown to have a positive inotropic and chronotropic effect. 12' 13 In this study the enddiastolic pressure of both right and left ventricles decreased, but as the stroke work of both ventricles decreased concurrently, no conclusion is possible regarding the effect on the ventricular function curves. The increase in heart rate could be due to a direct effect on the heart or could be secondary to a peripheral effect.
The stimulating effects of aminophylline on respiration were well shown in this study.
There was an increase in minute and alveolar ventilation. The increase in alveolar ventilation produced a significant decrease in arterial carbon dioxide tension, but no consistent change in arterial oxygen saturation. This confirms our previous observations in patients with cor pulmonale2 and also studies by Christensen and co-workers14 and Daly and Howard. 15 The failure consistently to increase arterial oxygen saturation in spite of the increase in alveolar ventilation and the increase in arterial pH indicates that aminophylline produced no consistent improvement in the abnormal ventilation-perfusion ratios present in chronic obstructive pulmonary disease under the conditions of this study.
